Price Analysis of Immunosuppressants Which are Approved By FDA as Anti-Rejection Therapy for Kidney Transplantation in the United States
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1801
https://www.valueinhealthjournal.com/article/S1098-3015(18)32123-5/fulltext
Title :
Price Analysis of Immunosuppressants Which are Approved By FDA as Anti-Rejection Therapy for Kidney Transplantation in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32123-5&doi=10.1016/j.jval.2018.04.1801
First page :
Section Title :
Open access? :
No
Section Order :
1004